TAK-071
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TAK-071, covering 2019-06-10 to 2024-05-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-071 in People With Parkinson Disease [Phase 2]